Literature DB >> 2083139

Early and delayed imaging with 123I-IMP SPECT in patients with ischemic cerebrovascular disease.

H Hoshi1, Y Yuki, S Kawano, S Jinnouchi, S Nagamachi, T Ohnishi, S Futami, K Watanabe, T Yano.   

Abstract

Cerebral blood flow imaging with N-isopropyl (I-123) p-iodoamphetamine (IMP) was performed in 44 patients with ischemic cerebrovascular disease (CVD) at an acute or subacute stage less than 30 days from the onset. IMP imaging was obtained at 20 minutes (early scan) and 4 hours (delayed scan) after intravenous injection of 222 MBq of IMP. The region of interest (ROI) was selected in a slice compatible with the findings on the CT images, and the lesion to tissue ratio (L/T ratio) was calculated in a comparison with the unaffected side. The redistribution index (RI) was also calculated by dividing the difference between the L/T ratio in early and delayed image by the L/T ratio in the early image. The patients were classified into three groups (Grade 1, 2, 3) on the basis of the CT findings. The L/T ratio in the delayed images and RI was high in grade 1 and 2 groups and low in grade 3 groups both in early and delayed scans. The RI had tendency to grow high as the days after the onset became later. In the duration period from 4 to 7 days, 'reversed' redistribution was observed in 4 cases. Follow up examinations were performed in 6 cases in grade 3 group. The RI became higher in 3 cases and lower in 3 cases in the second examination. In conclusion, good redistribution was observed in grade 1 and 2 groups, and the prognosis was good. On the other hand, poor redistribution was observed in grade 3 group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2083139     DOI: 10.1007/BF03164601

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  10 in total

1.  Evaluation of the significance of "redistribution" in I-123 IMP SPECT in cerebrovascular disorders--a comparative study with PET.

Authors:  M Tsukuda; Y Kuwabara; Y Ichiya; M Otsuka; T Tahara; Y Miyake; M Mizuguchi; R Gunasekera; K Masuda
Journal:  Eur J Nucl Med       Date:  1989

2.  Cerebral blood-flow tomography: xenon-133 compared with isopropyl-amphetamine-iodine-123: concise communication.

Authors:  N A Lassen; L Henriksen; S Holm; D I Barry; O B Paulson; S Vorstrup; J Rapin; M le Poncin-Lafitte; J L Moretti; S Askienazy; C Raynaud
Journal:  J Nucl Med       Date:  1983-01       Impact factor: 10.057

3.  Development of I-123-labeled amines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain.

Authors:  H S Winchell; R M Baldwin; T H Lin
Journal:  J Nucl Med       Date:  1980-10       Impact factor: 10.057

4.  Biodistribution of N-isopropyl-p-iodoamphetamine in the rat brain.

Authors:  H Hoshi; S Jinnouchi; K Watanabe; T Ueda; K Kinoshita; T Yamaguchi
Journal:  Nuklearmedizin       Date:  1987-06       Impact factor: 1.379

5.  Pathophysiologic study of chronic infarcts with I-123 isopropyl iodo-amphetamine (IMP): the importance of periinfarct area.

Authors:  C Raynaud; G Rancurel; Y Samson; J C Baron; J P Soucy; E Kieffer; E Cabanis; A Majdalani; S Ricard; A Bardy
Journal:  Stroke       Date:  1987 Jan-Feb       Impact factor: 7.914

6.  Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery.

Authors:  G Defer; J L Moretti; P Cesaro; A Sergent; C Raynaud; J D Degos
Journal:  Arch Neurol       Date:  1987-07

7.  Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.

Authors:  H Creutzig; O Schober; P Gielow; R Friedrich; H Becker; H Dietz; H Hundeshagen
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

8.  "Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke.

Authors:  J L Moretti; G Defer; L Cinotti; P Cesaro; J D Degos; N Vigneron; D Ducassou; B L Holman
Journal:  Eur J Nucl Med       Date:  1990

9.  Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography.

Authors:  D E Kuhl; J R Barrio; S C Huang; C Selin; R F Ackermann; J L Lear; J L Wu; T H Lin; M E Phelps
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

10.  N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain.

Authors:  H S Winchell; W D Horst; L Braun; W H Oldendorf; R Hattner; H Parker
Journal:  J Nucl Med       Date:  1980-10       Impact factor: 10.057

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.